Single-centre, single-blinded, randomised, parallel group, feasibility study protocol investigating if mandibular advancement device treatment for obstructive sleep apnoea can reduce nocturnal gastro-oesophageal reflux (MAD-Reflux trial)

INTRODUCTION: Just under half of patients with obstructive sleep apnoea (OSA) also have gastro-oesophageal reflux disease (GORD). These conditions appear to be inter-related and continual positive airway pressure (CPAP) therapy, the gold standard treatment for OSA to prevent airway collapse, has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Toole, Saoirse, Moazzez, Rebecca, Wojewodka, Gabriella, Zeki, Sebastian, Jafari, Jafar, Hope, Katherine, Brand, Andrew, Hoare, Zoe, Scott, Suzanne, Doungsong, Kodchawan, Ezeofor, Victory, Edwards, Rhiannon Tudor, Drakatos, Panagis, Steier, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450077/
https://www.ncbi.nlm.nih.gov/pubmed/37620257
http://dx.doi.org/10.1136/bmjopen-2023-076661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450077/
https://www.ncbi.nlm.nih.gov/pubmed/37620257
http://dx.doi.org/10.1136/bmjopen-2023-076661

Ejemplares similares